These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 23295942)

  • 1. Lithium chloride and inhibition of glycogen synthase kinase 3β as a potential therapy for serous ovarian cancer.
    Novetsky AP; Thompson DM; Zighelboim I; Thaker PH; Powell MA; Mutch DG; Goodfellow PJ
    Int J Gynecol Cancer; 2013 Feb; 23(2):361-6. PubMed ID: 23295942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Glycogen synthase kinase-3beta (GSK-3beta) promotes proliferation of ovarian cancer cells in vitro].
    Cao Q; Feng YJ
    Zhonghua Zhong Liu Za Zhi; 2006 Nov; 28(11):804-9. PubMed ID: 17415999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biphasic dose-dependent effect of lithium chloride on survival of human hormone-dependent breast cancer cells (MCF-7).
    Suganthi M; Sangeetha G; Gayathri G; Ravi Sankar B
    Biol Trace Elem Res; 2012 Dec; 150(1-3):477-86. PubMed ID: 23054864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of lithium chloride and antineoplastic drugs on survival and cell cycle of androgen-dependent prostate cancer LNCap cells.
    Azimian-Zavareh V; Hossein G; Janzamin E
    Indian J Pharmacol; 2012; 44(6):714-21. PubMed ID: 23248400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycogen synthase kinase 3β inhibition as a therapeutic approach in the treatment of endometrial cancer.
    Yin Y; Kizer NT; Thaker PH; Chiappinelli KB; Trinkaus KM; Goodfellow PJ; Ma L
    Int J Mol Sci; 2013 Aug; 14(8):16617-37. PubMed ID: 23941783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antagonist activity of the antipsychotic drug lithium chloride and the antileukemic drug imatinib mesylate during glioblastoma treatment in vitro.
    Aras Y; Erguven M; Aktas E; Yazihan N; Bilir A
    Neurol Res; 2016 Sep; 38(9):766-74. PubMed ID: 27367429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycogen synthase kinase 3β inhibitors induce apoptosis in ovarian cancer cells and inhibit in-vivo tumor growth.
    Hilliard TS; Gaisina IN; Muehlbauer AG; Gaisin AM; Gallier F; Burdette JE
    Anticancer Drugs; 2011 Nov; 22(10):978-85. PubMed ID: 21878813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of glycogen synthase kinase-3 beta (GSK-3β) by the Akt pathway in gliomas.
    Atkins RJ; Dimou J; Paradiso L; Morokoff AP; Kaye AH; Drummond KJ; Hovens CM
    J Clin Neurosci; 2012 Nov; 19(11):1558-63. PubMed ID: 22999562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lithium Chloride Promotes Apoptosis in Human Leukemia NB4 Cells by Inhibiting Glycogen Synthase Kinase-3 Beta.
    Li L; Song H; Zhong L; Yang R; Yang XQ; Jiang KL; Liu BZ
    Int J Med Sci; 2015; 12(10):805-10. PubMed ID: 26516309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of glycogen synthase kinase-3β by lithium chloride suppresses 6-hydroxydopamine-induced inflammatory response in primary cultured astrocytes.
    Wang HM; Zhang T; Li Q; Huang JK; Chen RF; Sun XJ
    Neurochem Int; 2013 Nov; 63(5):345-53. PubMed ID: 23871716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination therapy with histone deacetylase inhibitors and lithium chloride: a novel treatment for carcinoid tumors.
    Adler JT; Hottinger DG; Kunnimalaiyaan M; Chen H
    Ann Surg Oncol; 2009 Feb; 16(2):481-6. PubMed ID: 19030935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of glycogen synthase kinase-3β inhibitor AZD1080 in ovarian cancer.
    Chen S; Sun KX; Feng MX; Sang XB; Liu BL; Zhao Y
    Drug Des Devel Ther; 2016; 10():1225-32. PubMed ID: 27051274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inactivation of glycogen synthase kinase-3beta, a downstream target of the raf-1 pathway, is associated with growth suppression in medullary thyroid cancer cells.
    Kunnimalaiyaan M; Vaccaro AM; Ndiaye MA; Chen H
    Mol Cancer Ther; 2007 Mar; 6(3):1151-8. PubMed ID: 17363508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analyses of merlin/NF2 connection to FAK inhibitor responsiveness in serous ovarian cancer.
    Shah NR; Tancioni I; Ward KK; Lawson C; Chen XL; Jean C; Sulzmaier FJ; Uryu S; Miller NL; Connolly DC; Schlaepfer DD
    Gynecol Oncol; 2014 Jul; 134(1):104-11. PubMed ID: 24786638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lithium chloride and staurosporine potentiate the accumulation of phosphorylated glycogen synthase kinase 3β/Tyr216, resulting in glycogen synthase kinase 3β activation in SH-SY5Y human neuroblastoma cell lines.
    Noël A; Barrier L; Rinaldi F; Hubert C; Fauconneau B; Ingrand S
    J Neurosci Res; 2011 May; 89(5):755-63. PubMed ID: 21360572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycogen synthase kinase-3beta positively regulates the proliferation of human ovarian cancer cells.
    Cao Q; Lu X; Feng YJ
    Cell Res; 2006 Jul; 16(7):671-7. PubMed ID: 16788573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of inhibition of glycogen synthase kinase-3 on cardiac hypertrophy during acute pressure overload.
    Tateishi A; Matsushita M; Asai T; Masuda Z; Kuriyama M; Kanki K; Ishino K; Kawada M; Sano S; Matsui H
    Gen Thorac Cardiovasc Surg; 2010 Jun; 58(6):265-70. PubMed ID: 20549454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of Akt mRNA and protein levels by glycogen synthase kinase-3beta in adrenal chromaffin cells: effects of LiCl and SB216763.
    Nemoto T; Kanai T; Yanagita T; Satoh S; Maruta T; Yoshikawa N; Kobayashi H; Wada A
    Eur J Pharmacol; 2008 May; 586(1-3):82-9. PubMed ID: 18395711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lithium inhibits proliferation of human esophageal cancer cell line Eca-109 by inducing a G2/M cell cycle arrest.
    Wang JS; Wang CL; Wen JF; Wang YJ; Hu YB; Ren HZ
    World J Gastroenterol; 2008 Jul; 14(25):3982-9. PubMed ID: 18609681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lithium stimulates proliferation in cultured thyrocytes by activating Wnt/beta-catenin signalling.
    Rao AS; Kremenevskaja N; Resch J; Brabant G
    Eur J Endocrinol; 2005 Dec; 153(6):929-38. PubMed ID: 16322400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.